Sponsor or institution

Clinical trials and research at Spanish Breast Cancer Research Group

As of November 12, 2026, Find a Trial lists 4 clinical trials run by Spanish Breast Cancer Research Group that are recruiting, in Spain. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest trials

StudyPhaseWhereStatusRegistered
Exploring ctDNA in early breast cancer before and after neoadjuvant therapy — San Sebastián, Guipúzcoa and 9 other locations Recruiting Jul 22, 2026
Exercise and Quality of Life for Early-Stage Hormone Receptor–Positive/HER2-Negative Breast Cancer on Adjuvant Therapy — L'Hospitalet de Llobregat, Barcelona and 4 other locations Recruiting Oct 10, 2025
Long-term follow-up of early stage breast cancer patients — Pamplona, Navarre and 72 other locations Recruiting Jan 4, 2018
Registry for patients with advanced or metastatic breast cancer — Elche, Alicante and 39 other locations Recruiting Jun 30, 2016

All recruiting trials (4)

Quick answers

How many clinical trials run by Spanish Breast Cancer Research Group are recruiting right now?

4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in Spain. Each study page lists its sites and which ones are recruiting.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.